StockData
ClearPoint Neuro, Inc. logo

ClearPoint Neuro, Inc. (CLPT) stock

CLPTNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 4/3012% above fair value
$7.71−0.15 (-1.91%)

Close on Nov 18, 2026Market cap $247.14MP/E –Yield –

ClearPoint Neuro revenue

Revenue is the money a company takes in from selling its products and services, before any costs are deducted.

ClearPoint Neuro's revenue for the twelve months ending Sep 30, 2026 was $45.49M, up 32.5% year over year. For fiscal 2025 it was $36.97M, up 17.8% from the year before. Over ten years it grew 23.2% a year on average. The highest annual figure on record is $36.97M in fiscal 2025.

Annual revenue

PeriodPeriod endValueChange
FY2025Dec 31, 2025$36.97M+17.8%
FY2024Dec 31, 2024$31.39M+31.0%
FY2023Dec 31, 2023$23.96M+16.6%
FY2022Dec 31, 2022$20.55M+26.1%
FY2021Dec 31, 2021$16.30M+27.0%
FY2020Dec 31, 2020$12.83M+14.4%
FY2019Dec 31, 2019$11.22M+52.5%
FY2018Dec 31, 2018$7.35M-0.4%
FY2017Dec 31, 2017$7.38M+28.4%
FY2016Dec 31, 2016$5.75M+25.1%
FY2015Dec 31, 2015$4.59M+27.5%
FY2014Dec 31, 2014$3.60M-8.3%
FY2013Dec 31, 2013$3.93M-22.3%
FY2012Dec 31, 2012$5.06M+32.5%
FY2011Dec 31, 2011$3.82M+43.0%
FY2010Dec 31, 2010$2.67M–

Quarterly revenue

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$12.08M+36.3%
Q2 FY2026Jun 30, 2026$10.88M+18.1%
Q1 FY2026Mar 31, 2026$12.13M+42.9%
Q4 FY2025Dec 31, 2025$10.41M+34.0%
Q3 FY2025Sep 30, 2025$8.86M+9.1%
Q2 FY2025Jun 30, 2025$9.22M+17.3%
Q1 FY2025Mar 31, 2025$8.49M+11.1%
Q4 FY2024Dec 31, 2024$7.77M+14.1%
Q3 FY2024Sep 30, 2024$8.12M+41.0%
Q2 FY2024Jun 30, 2024$7.86M+32.1%
Q1 FY2024Mar 31, 2024$7.64M+40.6%
Q4 FY2023Dec 31, 2023$6.81M+31.6%
Q3 FY2023Sep 30, 2023$5.76M+12.0%
Q2 FY2023Jun 30, 2023$5.95M+14.4%
Q1 FY2023Mar 31, 2023$5.43M+8.0%
Q4 FY2022Dec 31, 2022$5.17M+20.8%
Q3 FY2022Sep 30, 2022$5.15M+12.5%
Q2 FY2022Jun 30, 2022$5.20M+52.4%
Q1 FY2022Mar 31, 2022$5.03M+24.8%
Q4 FY2021Dec 31, 2021$4.28M+15.2%
Q3 FY2021Sep 30, 2021$4.57M+30.0%
Q2 FY2021Jun 30, 2021$3.41M+37.7%
Q1 FY2021Mar 31, 2021$4.03M+29.3%
Q4 FY2020Dec 31, 2020$3.72M+15.7%
Q3 FY2020Sep 30, 2020$3.52M+20.2%
Q2 FY2020Jun 30, 2020$2.48M-4.9%
Q1 FY2020Mar 31, 2020$3.12M+26.0%
Q4 FY2019Dec 31, 2019$3.21M+41.0%
Q3 FY2019Sep 30, 2019$2.93M+62.0%
Q2 FY2019Jun 30, 2019$2.61M+58.3%
Q1 FY2019Mar 31, 2019$2.47M+52.3%
Q4 FY2018Dec 31, 2018$2.28M+35.6%
Q3 FY2018Sep 30, 2018$1.81M+5.2%
Q2 FY2018Jun 30, 2018$1.65M-16.7%
Q1 FY2018Mar 31, 2018$1.62M-19.1%
Q4 FY2017Dec 31, 2017$1.68M+2.7%
Q3 FY2017Sep 30, 2017$1.72M–
Q2 FY2017Jun 30, 2017$1.98M–
Q1 FY2017Mar 31, 2017$2.01M–
Q4 FY2016Dec 31, 2016$1.64M–

More ClearPoint Neuro figures

See a number that looks wrong?